(Q38032025)

27 August 2017

0 references

Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

3

P Messa

1 reference

27 August 2017

F Fabrizi

1

1 reference

PubMed ID

22863263

27 August 2017

V Dixit

series ordinal

2

1 reference

PubMed ID

22863263

27 August 2017

language of work or name

1 reference

17 July 2012

1 reference

Journal of Viral Hepatitis

27 August 2017

1 reference

27 August 2017

19

1 reference

27 August 2017

9

1 reference

27 August 2017

601-607

1 reference

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Kidney disease and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

HEpiMA: software for the identification of heterogeneity in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Risk of death among chronic dialysis patients infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Hepatitis C virus and death risk in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Hepatitis status and mortality in hemodialysis population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Effect of kidney transplantation on outcomes among patients with hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

Hepatitis C infection in dialysis patients: a link to poor clinical outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01633.X

10.1111/J.1365-2893.2012.01633.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22863263